This indicates decreased copper binding to SOD1 specifically within the Parkinson disease SNc, which we speculate results from the combination of lower bioavailable copper [13] and higher SOD1 protein expression [85] we reported within this region. The gene discussed is SOD1; the disease is Parkinson disease.